Name: Relias Media
Price range: $

CDC Recommends RSV Vaccine for Patients in Third Trimester

Sep 27, 2023

The agency says this solution should be administered to patients during weeks 32 through 36 of pregnancy to protect babies against the dangerous virus, both before and shortly after birth.

The Current State of RSV

Jun 15, 2023

Respiratory syncytial virus is a common virus encountered in the ED, with myriad presentations and complications that clinicians must be able to identify and manage. The authors provide state-of-the-art diagnostic and management strategies for the acute care clinician.

May 4, 2023

FDA approved Arexvy to protect people age 60 years and older against the respiratory syncytial virus.

Mar 30, 2023

With some concerns and caveats that put a strong emphasis on post-marketing surveillance, vaccine advisors for the Food and Drug Administration have greenlit two vaccines against respiratory syncytial virus infections in people aged 60 years and older.

Mar 21, 2023

In older patients who are at risk for severe disease caused by respiratory syncytial virus (RSV), two new distinct vaccine candidates based on the stabilized prefusion F protein demonstrated efficacy and prevented RSV lower respiratory tract disease in patients older than age 60 years.

Jan 30, 2023

Young children hospitalized with respiratory syncytial virus (RSV) infection are at increased risk of subsequent hospitalization during the following year and of increased need for outpatient healthcare.

RSV and Respiratory Illness Resources

Nov 17, 2022

This collection of commentaries, monographs, blog posts, and news pieces about respiratory illnesses (with a focus on respiratory syncytial virus) will help providers navigate the choppy waters of diagnosis and treatment as cold and flu season settles in upon the country.

Oct 26, 2022

Respiratory syncytial virus is something of a contradiction: The leading cause of hospitalization of infants in the United States (58,000 annually) is largely unappreciated beyond the pediatric population.

Feb 11, 2022

Respiratory syncytial virus (RSV) is something of a contradiction: The leading cause of hospitalization of infants in the United States (58,000 annually) is largely unappreciated beyond the pediatric population. In what essentially is a hidden seasonal epidemic, RSV causes 177,000 hospitalizations and 14,000 deaths annually in the United States in those age 65 years and older.

Feb 4, 2022

Although respiratory syncytial virus (RSV) is a known threat in pediatrics, it has not been widely reported that RSV kills some 14,000 adults age 65 and over annually.

Jan 25, 2018

As of mid-January, about 9,000 Americans with laboratory-confirmed influenza had sought care for their respiratory ailments and were admitted to the hospital, according to data from the national Centers for Disease Control and Prevention.

Apr 17, 2017

This was the Apollo 13 of outbreaks—where just about everything that could go wrong did. And in that vein, those who tried valiantly to save all the lives they could embodied that doomed mission’s heroism. In this case, metaphorically speaking, everyone didn’t make it back.

Advanced Search

Search Results